Krystal Biotech Inc (KRYS) — Free Cash Flow Generation Index
Krystal Biotech Inc (KRYS) has a Free Cash Flow Generation Index of 0.95x as of June 2026. Free cash flow of $71.22 Million represents 1% of operating cash flow ($74.79 Million). Explore KRYS capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Krystal Biotech Inc Free Cash Flow Generation Index (2024–2025)
Historical FCF Generation Index trend for Krystal Biotech Inc across 2 annual periods. For the full cash flow conversion analysis, see Krystal Biotech Inc (KRYS) cash conversion ratio.
Annual Free Cash Flow Generation for Krystal Biotech Inc (2024–2025)
Year-by-year Free Cash Flow Generation Index for Krystal Biotech Inc. Check Krystal Biotech Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.94x | $188.91 Million | $200.87 Million | $11.95 Million | ▼ -2.6% |
| 2024 | 0.97x | $119.18 Million | $123.42 Million | $4.24 Million | — |